Lonza Group (FRA:LO3A) Cyclically Adjusted PB Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LO3A Lonza Group Ltd FRA:LO3A
81 GF Score
Price €57.00
GF Value €61.69
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Lonza Group Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Lonza Group  (FRA:LO3A) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Lonza Group Cyclically Adjusted PB Ratio Related Terms


Lonza Group Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Lonza Group's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lonza Group Cyclically Adjusted PB Ratio Chart

Lonza Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.05 6.31 4.29 5.71 5.30

Lonza Group Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.65 5.96 5.97 5.48 5.32

FRA:LO3A vs TMO, DHR, NTRA: Cyclically Adjusted PB Ratio Comparison

For the Diagnostics & Research subindustry, Lonza Group's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lonza Group Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lonza Group's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lonza Group's Cyclically Adjusted PB Ratio falls into.


FRA:LO3A
81GF Score
Lonza Group Ltd FRA:LO3A
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lonza Group Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Lonza Group's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec25 is calculated as:

For example, Lonza Group's adjusted Book Value per Share data for the fiscal year that ended in Dec25 was:

Adj_Book=Book Value per Share/CPI of Dec25 (Change)*Current CPI (Dec25)
=12.258/107.2000*107.2000
=12.258

Current CPI (Dec25) = 107.2000.

Lonza Group Annual Data

Book Value per Share CPI Adj_Book
201612 3.855 99.380 4.158
201712 7.115 100.213 7.611
201812 7.518 100.906 7.987
201912 8.130 101.063 8.624
202012 8.568 100.241 9.163
202112 12.778 101.776 13.459
202212 14.540 104.666 14.892
202312 14.187 106.461 14.285
202412 14.163 107.128 14.173
202512 12.258 107.200 12.258

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Lonza Group (FRA:LO3A) Overvalued in 2026?

Based on GuruFocus' analysis, Lonza Group stock appears to be undervalued. The current stock price of €57.00 is trading 7.6% below its estimated GF Value™ of €61.69. GuruFocus considers Lonza Group to be Fairly Valued.

Key valuation signals for FRA:LO3A:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €61.69 vs. price of €57.00 (7.6% below fair value)
  • GF Score™: 81/100 with 2 warning signs

No single metric tells the full story. See the FRA:LO3A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lonza Group Business Description

Address Muenchensteinerstrasse 38, Basel, CHE, 4002
Lonza Group is a contract development and manufacturing organization. It operates under four segments: small molecules, biologics, cell and gene, and capsules and health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides development and manufacturing services throughout the entire lifecycle of a product, from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.
81GF Score

Get the complete analysis for FRA:LO3A

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€57.00
Price
€61.69
GF Value